First blood test to help diagnose Alzheimers goes public – Axios
A non-COVID medical breakthrough: People over 60 now have access to a blood test for Alzheimer's disease.
Why it matters: The existing PET brain scan test costs some people about $5,000 and often isn't covered by insurance, AP reports.
Both the blood test and the brain scan are looking for a buildup of a protein called beta-amyloid, which combined with symptoms like memory loss can lead to a dementia diagnosis.
The test hasn't received FDA approval, and it's being sold under rules for commercial labs.
The big picture: Roughly 5.5 million Americans may have Alzheimer's-induced dementia, the NIH reports.
Earlier diagnoses can't stop the disease, the NIH notes, but treatments can prolong the period before people lose the ability to function on their own.
Between the lines: C2N Diagnostics ...